Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024European Heart Journal Acute Cardiovascular CareOpen Access

Reperfusion therapies in patients with intermediate- and high-risk pulmonary embolism: insights from a multicenter registry

View Full Paper
Ask AI
Bookmark
Share

Authors

CRCarlos RealCFCarlos FerreraMVMa Eugenia Vázquez-Álvarez

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Real et al. (2024) studied this question.

synapsesocial.com/papers/68e70f02b6db643587688d7bhttps://doi.org/10.1093/ehjacc/zuae036.009
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1F-24 | Trends in thrombolytic therapies for acute pulmonary embolism from 2016 – 20202024
  2. 2Systemic thrombolysis vs catheter-directed interventions for the treatment of high-risk pulmonary embolism. A comparative analysis of early outcomes and complications2025
  3. 3Impact of reperfusion therapies on clot resolution and long-term outcomes in patients with pulmonary embolism: a retrospective observational study2023
  4. 4Percutaneous Reperfusion Therapies vs. Anticoagulation in Patients With Acute Intermediate‐High‐Risk Pulmonary Embolism: The PRETHA Randomized Clinical Trial2026 · 1 citations
  5. 5Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients2022 · 36 citations